
pmid: 16876030
In adults, symptomatic scoliosis is usually a de novo primary degenerative deformity that develops in the fifth or sixth decade or an unrecognized or untreated idiopathic deformity with superimposed degeneration. The evaluation and treatment of adult scoliosis must focus on addressing patient symptoms while limiting the consequences of the treatment. The presence of neurological deficits, the flexibility of the deformity, the coronal and sagittal balance, and status of spinal segments outside of the main deformity are all important considerations when planning surgery. The complication rate of deformity surgery in adults is potentially high; but excellent functional outcome and patient satisfaction can occur with thorough preoperative patient education and meticulous surgical technique.
Adult, Lumbar Vertebrae, Bone Morphogenetic Protein 2, Internal Fixators, Biological Factors, Scoliosis, Transforming Growth Factor beta, Bone Morphogenetic Proteins, Humans, Orthopedic Procedures, Intervertebral Disc
Adult, Lumbar Vertebrae, Bone Morphogenetic Protein 2, Internal Fixators, Biological Factors, Scoliosis, Transforming Growth Factor beta, Bone Morphogenetic Proteins, Humans, Orthopedic Procedures, Intervertebral Disc
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 74 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
